Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain

BSE362.7031.55 (+9.53 %)

PREV CLOSE ( ) 331.15

OPEN PRICE ( ) 337.40

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9068

TODAY'S LOW / HIGH ( )335.00 370.00

52 WK LOW / HIGH ( )282.15 581

NSE363.2530.95 (+9.31 %)

PREV CLOSE( ) 332.30

OPEN PRICE ( ) 333.00

BID PRICE (QTY) 363.25 (272)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 274174

TODAY'S LOW / HIGH( ) 333.00 369.95

52 WK LOW / HIGH ( )281.1 581.9

Quarters

Select year

( in Million)

Particulars

Sep 2025

Jun 2025

Mar 2025

Dec 2024

Audited / UnAudited

UnAudited

Net Sales

1411.3

1667

1325.3

1634.9

Total Expenditure

1589.2

1678.8

1594.1

1555.3

PBIDT (Excl OI)

-177.9

-11.8

-268.8

79.60

Other Income

56.7

85.9

36.2

Operating Profit

-113.9

44.90

-182.9

115.8

Interest

21.4

8.6

10.4

9.9

Exceptional Items

113.2

277.1

27.7

PBDT

-108.3

149.5

83.79

133.6

Depreciation

83.4

83.9

84.2

89.8

Profit Before Tax

-191.7

65.60

-0.40

43.79

Tax

-51.6

19.5

-0.6

Provisions and contingencies

Profit After Tax

-140.1

39.60

-19.90

44.39

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

-140.1

39.60

-19.90

44.39

Minority Interest

0.9

0.8

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

-139.2

40.5

-18.9

45.2

Equity Capital

61.3

Face Value (IN RS)

Reserves

Calculated EPS

-2.27

0.66

-0.30

0.73

Calculated EPS (Annualised)

-9.08

2.64

-1.23

2.94

No of Public Share Holdings

16856556

16851556

% of Public Share Holdings

27.52

27.51

PBIDTM% (Excl OI)

-12.60

-0.70

-20.28

4.86

PBIDTM%

-8.07

2.69

-13.80

7.08

PBDTM%

-7.67

8.96

6.32

8.17

PBTM%

-13.58

3.93

-0.03

2.67

PATM%

-9.92

2.37

-1.50

2.71

Notes

Risk Disclosures on Derivatives

Quarterly Results

PANACEA BIOTEC LTD.